US Patent 10233251 Antibody therapeutics that bind CD137
Patent 10233251 was granted and assigned to Sorrento Therapeutics on March, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10233251 Antibody therapeutics that bind CD137
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
